Retail sale of pharmaceutical products
FARSUND APOTEK AS
Revenue 2024
NOK 11.7m
Operating profit
NOK 220,000
Equity
NOK 915,000
Incorporated
2023
Share capital
NOK 1.0m
Key figures · 2024
Current ratio
1.80
Equity ratio
25.7%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 1.9% | |
| Net margin (%%) | 0.9% | |
| Return on assets (%%) | 6.2% | |
| Likviditet | ||
| Current ratio | 1.80 | |
| Working capital | 1.1m | |
| Soliditet | ||
| Equity ratio (%%) | 25.7% | |
| Debt-to-equity ratio | 2.90 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.